Skip to content

Study on the regulation mechanism of acupuncture on sex hormones in patients with POI based on metabonomics

Study on the regulation mechanism of acupuncture on sex hormones in patients with POI based on metabonomics

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049274
Enrollment
Unknown
Registered
2021-07-28
Start date
2019-10-17
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premature ovarian insufficiency

Interventions

Sponsors

The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) meeting the diagnostic criteria of Poi; (2) 18 to 40 years of age; (3) no other treatment for 2 months before admission; (4) patients participated in this study voluntarily and actively participated in the trial; (5) signed consent form; Those who met the above 6 criteria were included in the study.

Exclusion criteria

Exclusion criteria: (1) congenital abnormalities of the reproductive organs; Polycystic Ovary Syndrome; Hyperprolactinaemia, pituitary or Hypothalamus Amenorrhea and thyroid dysfunction; congenital malformation of the reproductive organs and organic lesions; (2) history of local ovarian surgery, for example, after ovariectomy, ovarian tumor operation, history of chemotherapy or pelvic radiotherapy, history of immunosuppressive therapy; (3) complicated with serious diseases of cardiovascular system, liver, kidney, hematopoiesis system, nervous and mental system, diabetes and hypertension; (4) could not tolerate blood or ultrasound examination and acupuncture treatment in the course of this study; (5) failure to complete the total number of acupuncture treatments; (6) refusal to sign the informed consent form;

Design outcomes

Primary

MeasureTime frame
Antimullerian hormone;

Secondary

MeasureTime frame
three sex hormones;antral follicle count;

Countries

China

Contacts

Public ContactZhang Wei

The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

zw_69996@163.com15278860187

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026